Skip header and navigation

21 records – page 1 of 2.

Regulation of Self-Care Products in Canada

https://policybase.cma.ca/en/permalink/policy13802
Date
2016-Oct-31
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Health care and patient safety
  1 document  

Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada

https://policybase.cma.ca/en/permalink/policy13936
Date
2016-Oct-18
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
Health care and patient safety
  1 document  

Legalization, regulation and restriction of access to marijuana

https://policybase.cma.ca/en/permalink/policy11954
Date
2016-Aug-29
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  2 documents  

Unique challenges of managing pain in older adults

https://policybase.cma.ca/en/permalink/policy11900
Date
2016-Aug-24
Topics
Ethics and medical professionalism
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC16-29
The Canadian Medical Association recommends research into and education for health care providers concerning the unique challenges of managing pain in older adults.
Policy Type
Policy resolution
Date
2016-Aug-24
Topics
Ethics and medical professionalism
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC16-29
The Canadian Medical Association recommends research into and education for health care providers concerning the unique challenges of managing pain in older adults.
Less detail

Canadian guideline for safe and effective use of opioids for chronic pain

https://policybase.cma.ca/en/permalink/policy11901
Date
2016-Aug-24
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC16-30
The Canadian Medical Association recommends that the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain include consideration of pharmacokinetic and pharmacodynamic factors specific to older adults.
Policy Type
Policy resolution
Date
2016-Aug-24
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC16-30
The Canadian Medical Association recommends that the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain include consideration of pharmacokinetic and pharmacodynamic factors specific to older adults.
Less detail

Standardized non-pharmacologic order sets

https://policybase.cma.ca/en/permalink/policy11903
Date
2016-Aug-24
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC16-32
The Canadian Medical Association advocates for the development of national standardized non-pharmacologic order sets for the treatment of older adults with delirium.
Policy Type
Policy resolution
Date
2016-Aug-24
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC16-32
The Canadian Medical Association advocates for the development of national standardized non-pharmacologic order sets for the treatment of older adults with delirium.
Less detail

Public funding of insulin and other diabetes-related supplies

https://policybase.cma.ca/en/permalink/policy11909
Date
2016-Aug-24
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC16-39
The Canadian Medical Association endorses public funding of insulin and other diabetes-related supplies for all patients with insulin-dependent diabetes.
Policy Type
Policy resolution
Date
2016-Aug-24
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC16-39
The Canadian Medical Association endorses public funding of insulin and other diabetes-related supplies for all patients with insulin-dependent diabetes.
Less detail

Bill C-224, Good Samaritan Drug Overdose Act

https://policybase.cma.ca/en/permalink/policy11910
Date
2016-Aug-24
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC16-40
The Canadian Medical Association supports Bill C-224, Good Samaritan Drug Overdose Act.
Policy Type
Policy resolution
Date
2016-Aug-24
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC16-40
The Canadian Medical Association supports Bill C-224, Good Samaritan Drug Overdose Act.
Less detail

Patients access to their electronic medical record

https://policybase.cma.ca/en/permalink/policy11924
Date
2016-Aug-24
Topics
Health information and e-health
Resolution
GC16-49
The Canadian Medical Association recommends that patients be able to access their electronic medical record and contribute information to it.
Policy Type
Policy resolution
Date
2016-Aug-24
Topics
Health information and e-health
Resolution
GC16-49
The Canadian Medical Association recommends that patients be able to access their electronic medical record and contribute information to it.
Less detail

Funding criteria for any new electronic medical record initiative

https://policybase.cma.ca/en/permalink/policy11925
Date
2016-Aug-24
Topics
Health systems, system funding and performance
Health information and e-health
Resolution
GC16-50
The Canadian Medical Association recommends that funding criteria for any new electronic medical record initiative include the ability for patients to access and contribute to their record.
Policy Type
Policy resolution
Date
2016-Aug-24
Topics
Health systems, system funding and performance
Health information and e-health
Resolution
GC16-50
The Canadian Medical Association recommends that funding criteria for any new electronic medical record initiative include the ability for patients to access and contribute to their record.
Less detail

Health Canada’s Consultation on “Plain and Standardized Packaging”

https://policybase.cma.ca/en/permalink/policy13817
Date
2016-Aug-12
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  

National pharmacare in Canada: Getting there from here

https://policybase.cma.ca/en/permalink/policy11959
Date
2016-Jun-01
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  

Consultation on the prescription drug list: Naloxone

https://policybase.cma.ca/en/permalink/policy11847
Date
2016-Mar-17
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  

Guiding principles for the optimal use of data analytics by physicians at the point of care

https://policybase.cma.ca/en/permalink/policy11812
Date
2016-Feb-27
Topics
Health information and e-health
  1 document  

Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.

https://policybase.cma.ca/en/permalink/policy11814
Date
2016-Jan-20
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Health care and patient safety
  1 document  

Letter on cross-border pharmacy control

https://policybase.cma.ca/en/permalink/policy1947
Date
2005-Nov-08
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  

Study on Mental Health, Mental Illness and Addiction in Canada : Supplementary Submission to the Senate Standing Committee on Social Affairs, Science and Technology

https://policybase.cma.ca/en/permalink/policy1945
Date
2005-Oct-11
Topics
Population health/ health equity/ public health
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  

Re-entry training positions

https://policybase.cma.ca/en/permalink/policy1902
Date
2005-Aug-17
Topics
Health information and e-health
Resolution
GC05-83
The Canadian Medical Association recommends to educational and licensing authorities, Provincial Governments and the Canadian Medical Forum a fourfold increase in re-entry training positions and elimination of associated return of service requirements.
Policy Type
Policy resolution
Last Reviewed
2019-Mar-03
Date
2005-Aug-17
Topics
Health information and e-health
Resolution
GC05-83
The Canadian Medical Association recommends to educational and licensing authorities, Provincial Governments and the Canadian Medical Forum a fourfold increase in re-entry training positions and elimination of associated return of service requirements.
Less detail

Mental Health, Mental Illness & Addiction : CMA Submission to the Standing Committee on Social affairs, Science and Technology

https://policybase.cma.ca/en/permalink/policy1950
Date
2005-Apr-20
Topics
Population health/ health equity/ public health
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  

Compensation for remote consultation

https://policybase.cma.ca/en/permalink/policy1505
Date
2004-Aug-18
Topics
Health human resources
Health information and e-health
Physician practice/ compensation/ forms
Resolution
GC04-41
The Canadian Medical Association recommends that provincial and territorial authorities recognize that any type of remote consultation such as telemedicine and teleconsultation is a medical act to be duly compensated.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
2004-Aug-18
Topics
Health human resources
Health information and e-health
Physician practice/ compensation/ forms
Resolution
GC04-41
The Canadian Medical Association recommends that provincial and territorial authorities recognize that any type of remote consultation such as telemedicine and teleconsultation is a medical act to be duly compensated.
Less detail

21 records – page 1 of 2.